![]() ![]() ![]() Isenberg-Grzeda E, Huband H, Lam H (2017) A review of cognitive screening tools in cancer. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. ![]() Joly F, Giffard B, Rigal O, De Ruiter MB, Small BJ, Dubois M, LeFel J, Schagen SB, Ahles TA, Wefel JS, Vardy JL, Pancré V, Lange M (2012) Castel H (2015) Impact of cancer and its treatments on cognitive function: advances in research From the Paris International Cognition and Cancer Task Force Symposium and Update Since. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.Īhles TA (2012) Brain vulnerability to chemotherapy toxicities Psycho-Oncology 21:1141–1148 In version 7.1, the language and memory domains presented higher scores and lower visuospatial ability.ĭespite similar overall scores being obtained with the two versions of the MoCA, there were item-specific differences that may compromise their interchangeable use.Īlternate forms Data accuracy Mental status and dementia tests Montreal Cognitive Assessment Psychometric. There were significant differences in the percentage of correct answers in 7 out of 12 tasks, being the highest for the copy of a geometric figure (more than twofold higher with version 7.3). For women with midrange scores, total scores were significantly higher in version 7.1. The Bland-Altman limits of agreement were - 3.70 to 3.88. The mean total scores were not statistically different between versions and the ICC was 0.890. Agreements between versions, regarding total, sub-domain, and task scores, were assessed using Bland-Altman plots and intraclass correlation coefficients (ICC). At the 3-year follow-up (n = 422), the 7.1 and 7.3 versions were applied at the beginning and at the end (approximately 1 h later) of this evaluation, respectively. Since learning effects could be overcome through the alternate use of two versions of the MoCA, we aimed to explore their interchangeability by comparing their overall, and domain- and task-specific, scores among patients with BCa.īCa patients from the NEON-BC cohort were evaluated with the MoCA, version 7.1, after diagnosis and after 1 year. The Montreal Cognitive Assessment (MoCA) is a widely used cognitive impairment screening tool, but practice effects must be considered for longitudinal assessments. cognitive performance of patients with breast cancer (BCa) may be affected by cancer and its treatments. 9 Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina da Universidade do Porto, Porto, Portugal. ![]() 8 Laboratório para a Investigação Integrativa e Translacional em Saúde Populacional (ITR), Porto, Portugal.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |